Truist Financial Corp Acadia Pharmaceuticals Inc Call Options Transaction History
Truist Financial Corp
- $66.7 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
345Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$924 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$194 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$133 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.49B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...